Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Erectile Dysfunction Market at $4.08 Billion, 2016-2020: Key Vendors are Bayer, Boston Scientific, Coloplast, Eli Lilly & Pfizer - Research and Markets

Research and Markets
Posted on: 12 Oct 16

Research and Markets has announced the addition of the "Global Erectile Dysfunction Market 2016-2020" report to their offering.

The analysts forecast the global erectile dysfunction treatment market to witness a slow growth in market size of USD 4.08 billion during the period 2016-2020.

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

The report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs. The report also includes a discussion of the key vendors operating in this market.

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Key vendors

  • Bayer
  • Boston Scientific
  • Coloplast
  • Eli Lilly
  • Pfizer

Other prominent vendors

  • Apricus Biosciences
  • Cristalia Produtos Quimicos Farmaceuticos
  • Dong-A Socio
  • Endo Pharmaceuticals
  • Futura Medical
  • Meda Pharmaceuticals
  • Promedon
  • SK Chemical
  • Teva Pharmaceuticals
  • Vivus
  • Zephyr Surgical Implants (ZSI)

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by type of ED drugs

Part 08: Market segmentation by type of ED device

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Key vendor analysis

Part 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/wmgp7j/global_erectile

View source version on businesswire.com: http://www.businesswire.com/news/home/20161012005712/en/

Business Wire
www.businesswire.com

Last updated on: 12/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.